# Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

> **NCT03549442** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 40 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **COMBINATION_PRODUCT:** BCMA CART + huCART19
- **COMBINATION_PRODUCT:** CART BCMA or CART BCMA + huCART19
- **COMBINATION_PRODUCT:** Single-dose infusion of CART BCMA or CART BCMA + huCART19
- **COMBINATION_PRODUCT:** BCMA CART + huCART19

## Key facts

- **NCT ID:** NCT03549442
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-09
- **Primary completion:** 2036-03
- **Final completion:** 2036-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03549442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03549442, "Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03549442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*